ASCO in 30: Immunotherapy controversy & less is just as good
About the Authors Reprints
Senior Writer, Science and Discovery (1956-2021)
Sharon covered science and discovery.
Senior Writer, Biotech
Adam Feuerstein is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. He's also a co-host of "The Readout LOUD" podcast.